See also this year's filing and all EDGAR filings for this company.
PDF Report 0001029125_2014_Panbela_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001029125, Panbela Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 432,843 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 19,198 |
| 3 | remainder_Assets | 80,220 |
| 4 | LiabilitiesCurrent | 663,695 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 6,458 |
| 7 | CostOfGoodsAndServicesSold | 558,465 |
| 8 | SellingGeneralAndAdministrativeExpense | 197,575 |
| 9 | ResearchAndDevelopmentExpense | 279,791 |
| 10 | remainder_Expenses | 168,414 |
| 11 | remainder_Revenues | 992,224 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 532,261 |
| 1 | Liabilities | 670,153 |
| 2 | Expenses | 1,204,245 |
| 3 | Revenues | 992,224 |
| 4 | StockholdersEquity | -137,892 |
| 5 | NetIncome | -212,021 |
| 6 | ComprehensiveNetIncome | -212,021 |
| 7 | BaseVar | 1,699,442 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.853 |
| 9 | EconomicCapitalRatio | 1.33 |